The study demonstrates that [des-Asp1]angiotensin I is rapidly converted by converting enzymes, supporting an alternative pathway for Angiotensin III formation.
Answers are grounded in this paper and cite their sources.
Supports alternative angiotensin III pathway in vitro; leaves open physiological relevance in vivo.
A III), respectively, was studied in aortic strips, left atria, adrenal zone glomerulosa cell suspensions from rabbits, and with purified rabbit lung converting enzyme. Conversion of A I and [des'-A I] was estimated in the presence and absence of Bothrops jararaca nonapeptide, converting enzyme inhibitor (CEI), by measuring the changes in peptide-induced tension development in aortas and atria and on steroidogenesis in cell suspensions. The liberation of histidyl-leucine from A I and des'-A I by the enzyme preparation was studied. Angiotensin I and des'-A I possessed 23% and 1% contractile activity (aorta), and 34% and 4% positive inotropic activity (atria), respectively, when compared to A II. Inhibition of aortic and atrial converting enzymes attenuated responses to A I and des'-A I without significantly altering responses to AH and A HI. The steroidogenic activity of A I and des'-A I in adrenal cells was dependent on conversion since treatment with CEI specifically abolished aldosterone biosynthesis induced by A I and des'-A I without changing the activities of A II or A III. The Km values for AI and des'-A I determined with lung enzyme were 80 /IM and 30 /IM, respectively. The hydrolysis of A I and des'-A I was competitively inhibited by CEI, A II, and A HI. Angiotensin III was the most potent CEI among several metabolites of A I. These results indicate that des'-A I was a better substrate than A I for isolated pulmonary converting enzyme. The present investigation clearly indicates that des'-A I is rapidly converted by purified and tissue converting enzymes. The data are consistent with the postulated alternative pathway for formation of A HI from des'-A I subsequent to N-terminal degradation of A I.
No takes yet. Share an insight, caveat, or question.
Ackerly et al. (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: